List of drugs in development for neurodegenerative diseases. Update June 2004.
Kwon
Myoung-Ok
MO
Corporate Research, Novartis International AG, Basel , Switzerland.
Fischer
Frauke
F
Matthisson
Mark
M
Herrling
Paul
P
D018795:Device Approval; D015195:Drug Design; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009465:Neuromuscular Agents; D018696:Neuroprotective Agents; D018697:Nootropic Agents
D009465:Neuromuscular Agents; D018696:Neuroprotective Agents; D018697:Nootropic Agents